According to Gram Research analysis, babies who skip vitamin K shots at birth are 1.5 times more likely to experience bleeding and nearly 3 times more likely to have dangerous brain bleeding in their first 6 months of life, according to a 2026 Swedish study of over 2 million births. Vitamin K is a simple, proven preventive treatment that helps blood clot properly, and this research confirms its critical importance for newborn safety.
A large study from Sweden tracked over 2 million babies born between 2003 and 2021 to understand how often newborns skip vitamin K shots and what happens when they do. Vitamin K is a nutrient that helps blood clot properly. The research found that babies who didn’t get the vitamin K shot were much more likely to experience dangerous bleeding, especially in the brain. While most Swedish babies still receive this protective shot, the number refusing it has been slowly increasing, making this an important reminder for parents about this simple but life-saving prevention.
Key Statistics
A 2026 cohort study of 2,020,302 Swedish births found that infants without intramuscular vitamin K administration had 1.52-fold higher odds of bleeding episodes during infancy compared with infants who received the injection.
According to a 2026 Swedish study tracking over 2 million births, babies who did not receive vitamin K shots had 2.91-fold higher odds of intracranial hemorrhage (dangerous brain bleeding) compared to babies who received the preventive treatment.
A 2026 analysis of Swedish birth records showed that the rate of parents refusing vitamin K shots for newborns more than doubled from 0.66% in 2006 to 1.50% in 2021, despite strong evidence of its protective benefits.
Research from 2026 examining 2,020,302 Swedish births found that among 24,089 infants who did not receive vitamin K at birth, significantly higher rates of bleeding diagnoses were recorded during the first 6 months of life compared to vaccinated infants.
The Quick Take
- What they studied: Whether babies who skip vitamin K shots at birth are more likely to have bleeding problems in their first 6 months of life
- Who participated: Over 2 million babies born in Sweden from 2003 to 2021, including about 24,000 who did not receive the vitamin K injection at birth
- Key finding: Babies without vitamin K shots were 1.5 times more likely to bleed and nearly 3 times more likely to have dangerous brain bleeding compared to babies who received the shot
- What it means for you: Vitamin K shots are a simple, proven way to prevent serious bleeding in newborns. If you’re having a baby, this research strongly supports getting this standard preventive treatment, though you should discuss any concerns with your doctor
The Research Details
Swedish researchers looked at records from all babies born in the country over an 18-year period (2003-2021) and followed them until 6 months old. They compared babies who received vitamin K shots with those who didn’t, tracking which babies developed bleeding problems. The researchers used medical records from multiple Swedish health databases to find accurate information about who got the shot and who had bleeding issues. They used statistical methods to account for other differences between the groups that might affect the results.
This type of study is called a cohort study, which means researchers follow a large group of people over time and compare outcomes between different groups. It’s a strong research design for understanding how common something is and what risks are associated with it. The Swedish healthcare system’s detailed record-keeping made this study possible, as researchers could access information on nearly every baby born in the country.
This research approach is important because vitamin K deficiency bleeding is rare, so researchers needed to study a huge number of babies to find enough cases to draw reliable conclusions. By looking at an entire country’s births over nearly two decades, the researchers could see real-world patterns and trends that wouldn’t be visible in smaller studies. The study also shows whether parental refusal of vitamin K is becoming more common, which is a public health concern.
This study is very reliable because it included nearly all babies born in Sweden during the study period (not just a sample), used official medical records rather than relying on people’s memories, and was published in a top medical journal (JAMA Pediatrics). The researchers adjusted their analysis to account for other factors that might affect bleeding risk. The main limitation is that the study was done in Sweden, which has excellent healthcare and record-keeping, so results might differ in other countries with different healthcare systems or populations.
What the Results Show
Among the 2 million babies studied, about 24,000 (just over 1%) did not receive vitamin K shots at birth. Importantly, the rate of babies not receiving vitamin K decreased from 1.32% in 2003 to a low of 0.66% in 2006, but then started climbing again, reaching 1.50% by 2021. This suggests that more parents are choosing to skip this preventive treatment in recent years.
Babies who didn’t get vitamin K shots had significantly higher rates of bleeding problems. Specifically, they were 1.54 times more likely to experience any bleeding episode during their first 6 months of life. Even more concerning, they were 3.18 times more likely to have intracranial hemorrhage—dangerous bleeding inside the brain—which is the most serious type of bleeding that can occur.
These differences remained significant even after researchers accounted for other factors that might affect bleeding risk, such as gestational age and other health conditions. The findings were consistent across the entire study period, showing that vitamin K’s protective effect was reliable over the 18 years studied.
The study found that the trend of parents refusing vitamin K has been gradually increasing since 2006, with the refusal rate more than doubling over the last 15 years of the study. This suggests that vaccine hesitancy or concerns about medical interventions may be influencing parental decisions about this preventive treatment. The research also showed that the protective effect of vitamin K was strongest for preventing the most dangerous type of bleeding (brain bleeding), which is exactly what this preventive treatment is designed to stop.
This research confirms what doctors have known for decades: vitamin K shots effectively prevent a rare but serious bleeding condition in newborns. Previous studies have shown that vitamin K deficiency bleeding occurs in about 1 in 60 to 1 in 500 babies who don’t receive the shot, depending on the type. This Swedish study provides updated, real-world evidence from a large population that the protective effect is real and substantial. The finding that refusal rates are increasing is new and concerning, as it suggests that despite strong medical evidence, more parents are declining this simple preventive measure.
The study was conducted in Sweden, which has universal healthcare and excellent medical record-keeping, so results might not apply exactly to other countries with different healthcare systems or populations. The study couldn’t determine why parents refused vitamin K—whether due to concerns about safety, philosophical beliefs, or other reasons. Additionally, while the study shows that babies without vitamin K had more bleeding, it doesn’t prove that vitamin K caused the difference, though the biological mechanism is well-understood. The study also couldn’t track all possible bleeding episodes, only those serious enough to be diagnosed and recorded in medical records.
The Bottom Line
Medical evidence strongly supports giving all newborns vitamin K shots as a standard preventive treatment (high confidence). This is recommended by major health organizations worldwide, including the American Academy of Pediatrics and the World Health Organization. If you have concerns about vitamin K, discuss them with your pediatrician rather than declining the treatment, as the risks of bleeding are well-documented and serious.
All parents and caregivers of newborns should know about this research. Healthcare providers should use this information when counseling parents about newborn care. Public health officials should consider this data when developing education campaigns about preventive care. Parents who have concerns about vaccines or medical interventions should understand that vitamin K is not a vaccine but a simple nutrient that prevents a specific, dangerous condition.
Vitamin K works immediately to help prevent bleeding. The protective effect is most important during the first weeks and months of life, when vitamin K deficiency bleeding is most likely to occur. The study followed babies for 6 months, which is the critical period when this bleeding risk is highest.
Frequently Asked Questions
Is the vitamin K shot safe for newborns?
Yes, vitamin K shots are safe and have been used for decades to prevent bleeding in newborns. This Swedish study of over 2 million babies confirms that the shot’s benefits far outweigh any risks. Serious side effects are extremely rare, while the bleeding it prevents can be life-threatening.
What happens if a baby doesn’t get a vitamin K shot?
According to a 2026 Swedish study, babies without vitamin K shots are nearly 3 times more likely to experience dangerous brain bleeding in their first 6 months of life. While this condition is rare, it can cause permanent disability or death, making prevention through the vitamin K shot critically important.
Why are more parents refusing vitamin K for their babies?
The 2026 Swedish research shows refusal rates doubled from 2006 to 2021, but the study didn’t investigate why parents declined the treatment. Reasons may include concerns about medical interventions, misinformation, or philosophical beliefs, though medical evidence strongly supports vitamin K’s safety and effectiveness.
Can vitamin K deficiency bleeding be treated after it happens?
While some bleeding can be treated, brain bleeding from vitamin K deficiency can cause permanent brain damage or death even with treatment. Prevention through the newborn vitamin K shot is far more effective and safer than trying to treat the condition after it develops.
Is vitamin K the same as a vaccine?
No, vitamin K is not a vaccine. It’s a nutrient that your body needs for blood clotting. The shot provides vitamin K directly to prevent a specific bleeding condition, whereas vaccines help your immune system fight infections. They work differently and serve different purposes.
Want to Apply This Research?
- Track newborn preventive care completion: Record the date vitamin K was administered and note any bleeding symptoms (unusual bruising, blood in stool or vomit, excessive bleeding from umbilical cord) to monitor for any concerning signs
- Use the app to create a newborn preventive care checklist that includes vitamin K administration, helping parents ensure all recommended preventive treatments are completed before leaving the hospital
- Set reminders for follow-up pediatric visits during the first 6 months of life where bleeding risk can be assessed, and use the app to document any health concerns that arise during this critical period
This article summarizes research findings and is not medical advice. Vitamin K administration is a standard preventive treatment recommended by major health organizations worldwide. All decisions about your newborn’s care should be made in consultation with your pediatrician or healthcare provider. If you have concerns about vitamin K or any newborn treatment, discuss them with your doctor before declining any recommended preventive care. In case of emergency symptoms such as unusual bleeding, bruising, or signs of distress in your infant, seek immediate medical attention.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.